Anumana expands AI cardiac care platform with support from Boston Scientific

Related Articles
Anumana Appoints Maulik Nanavaty as CEO
Anumana Appoints Maulik Nanavaty as CEOCAMBRIDGE, Mass. – October 19, 2023 – Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, today announced that Maulik Nanavaty…October 19, 2023
Building sEHR-BERT: A Custom Language Model for Structured Electronic Health Records – Adapting transformer architecture for the unique challenges of medical coding and structured health data
Why Standard BERT Isn't Enough for Structured EHRs BERT revolutionized natural language processing, but electronic health records (EHRs) present unique challenges that standard language models weren't designed to handle. While BERT…January 22, 2026
Anumana Appoints Dr. Simos Kedikoglou as President and Chief Operating Officer
Anumana appoints new President and COOJanuary 09, 2025
Anumana’s AI algorithm for cardiac amyloidosis gets FDA breakthrough nod
Bioworld: Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early identification of cardiac amyloidosis. The ECG-AI detection algorithm is the…June 21, 2023


